Date published: 2025-11-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

R(+)-6-Bromo-APB hydrobromide (CAS 139689-19-3)

0.0(0)
Write a reviewAsk a question

Alternate Names:
1H-3-benzazepine hydrobromide
CAS Number:
139689-19-3
Molecular Weight:
455.18
Molecular Formula:
C19H21Br2NO2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

R(+)-6-Bromo-APB hydrobromide, a brominated derivative of the parent compound APB, is an agent of considerable interest in neuroscience research due to its action on serotonergic systems. It is used to study the properties of serotonin (5-HT) receptors, specifically in the context of its agonist activity on the 5-HT2B receptor subtype. This compound helps in characterizing the signal transduction pathways and physiological functions mediated by these receptors, such as their role in the central nervous system and the gastrointestinal tract. Additionally, R(+)-6-Bromo-APB hydrobromide is employed in receptor binding assays to understand the affinity and selectivity of compounds for the 5-HT2B receptor, providing a clearer picture of receptor-ligand interactions. It serves as useful for mapping the distribution of serotonin receptors and for dissecting out the complexities of serotonergic modulation within various biological systems.


R(+)-6-Bromo-APB hydrobromide (CAS 139689-19-3) References

  1. Oxidant-induced cardiomyocyte injury: identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay.  |  Gerö, D., et al. 2007. Int J Mol Med. 20: 749-61. PMID: 17912470
  2. Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis.  |  Módis, K., et al. 2009. Br J Pharmacol. 158: 1565-78. PMID: 19906119
  3. An image-based, high-throughput screening assay for molecules that induce excess DNA replication in human cancer cells.  |  Zhu, W., et al. 2011. Mol Cancer Res. 9: 294-310. PMID: 21257818
  4. Bioluminescence-based high-throughput screen identifies pharmacological agents that target neurotransmitter signaling in small cell lung carcinoma.  |  Improgo, MR., et al. 2011. PLoS One. 6: e24132. PMID: 21931655
  5. Identification of agents that reduce renal hypoxia-reoxygenation injury using cell-based screening: purine nucleosides are alternative energy sources in LLC-PK1 cells during hypoxia.  |  Szoleczky, P., et al. 2012. Arch Biochem Biophys. 517: 53-70. PMID: 22100704
  6. Adrenergic receptor-mediated modulation of striatal firing patterns.  |  Ohta, H., et al. 2016. Neurosci Res. 112: 47-56. PMID: 27287299
  7. A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells.  |  Seo, HH., et al. 2017. Biol Res. 50: 1. PMID: 28100269
  8. Pharmacological perturbation of thiamine metabolism sensitizes Pseudomonas aeruginosa to multiple antibacterial agents.  |  Kim, HJ., et al. 2022. Cell Chem Biol. 29: 1317-1324.e5. PMID: 35901793
  9. Mu opioid receptor mRNA in nucleus accumbens is elevated following dopamine receptor activation.  |  Azaryan, AV., et al. 1996. Neurochem Res. 21: 1411-5. PMID: 8947931
  10. Agonist-specific coupling of a cloned Drosophila melanogaster D1-like dopamine receptor to multiple second messenger pathways by synthetic agonists.  |  Reale, V., et al. 1997. J Neurosci. 17: 6545-53. PMID: 9254667
  11. Dopamine constricts porcine pial veins.  |  Sun, MH., et al. 1997. Eur J Pharmacol. 334: 165-71. PMID: 9369345
  12. Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration.  |  Azaryan, AV., et al. 1998. Can J Physiol Pharmacol. 76: 278-83. PMID: 9673791
  13. Development of predictive models by adaptive fuzzy partitioning. Application to compounds active on the central nervous system  |  Ros, F., Taboureau, O., Pintore, M., & Chretien, J. R. 2003. Chemometrics and intelligent laboratory systems. 67(1): 29-50.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

R(+)-6-Bromo-APB hydrobromide, 25 mg

sc-301656
25 mg
$700.00